News & Notes 2 | Middle and West Tennessee items
From Franklin:
Tod Reed will join Lynch Regenerative Medicine LLC (LRM) as a Senior Strategic Advisor after his recent retirement as the Senior Vice President, U.S. Sales and Sales Training, at Allergan Aesthetics, an Abbvie company.
In the new role, Reed brings 37 years of experience with Allergan to the LRM team, including more than 20 years in aesthetic and regenerative medicine. During his tenure at Allergan Aesthetics, Reed was responsible for helping build the largest sales organization in U.S. medical aesthetics while helping launch iconic brands such as Botox Cosmetic®, Juvederm®, and many other products in skin care, body contouring and aesthetic surgery. He was also responsible in the U.S. market for the renowned practice consulting group, strategic accounts, sales force operations and the sales training department.
“At LRM, we are building a leading regenerative medicine and aesthetics company based on the most proven and trusted science in the industry, combined with the some of the most experienced, talented and trusted people in aesthetics and regenerative medicine,” said Dr. Samuel Lynch, Founder and Chief Executive Officer of LRM. “Tod’s leadership at Allergan Aesthetics helped build it into the world’s largest aesthetic medicine company. We welcome him to the LRM team, where we strive every day to bring the best products together with the best people to advance the regenerative medicine and aesthetics fields.”
LRM’s first product to improve skin aesthetics, AriessenceTM Pure PDGF+, is available in leading innovative med/spa clinics and other aesthetic-focused offices, including dermatology and plastic surgery practices. Ariessence Pure PDGF+ is used topically to improve aesthetic outcomes associated with procedures such as micro-needling, dermabrasion, lasers, plastic surgery, and other procedures in which healthier-looking skin can be accelerated and enhanced using growth factors such as PDGF.
From Murfreesboro:
Middle Tennessee State University’s School of Journalism and Strategic Media has launched a student-powered communications agency intended to boost area businesses while providing students with job-ready experiences in a fully functioning agency.
Named Ever Blue Branding, the agency started earlier this year and helps clients with a wide range of communication materials and services ranging from strategic planning, brand building and integrated campaigns to trend reports, market research, consumer studies, Search Engine Optimization, and communication audits.
To be involved with Ever Blue Branding, students must be enrolled in one of the three classes — Ever Blue Branding I, Ever Blue Branding II or Ever Blue Branding III. Students do not have to have a major in the College of Media and Entertainment to be involved.
Another from Franklin:
Adora Animal Health Corporation has announced that its first U.S. patent has published. The issued patent (U.S. Patent 12,059,430) pertains to processes to prepare a purified form of the active ingredient in Adora’s injectable veterinary generic PSGAG, which is currently marketed by American Regent as Adequan®. Adequan is approved for use in equine and canine applications. There is currently no approved generic for this important veterinary medicine.
Adora’s U.S.-based contract manufacturing organization partner is Kinentia Biosciences which harnessed the power of diafiltration and particle size exclusion technologies to control the purity and manufacturing output of sulfated aminoglycans used in treating arthritic pain and other medical conditions. These technologies represent an improvement in processes to remove low molecular weight reaction impurities and byproducts from existing methods to prepare this high molecular weight and important medicine.
PSGAG is prepared from chondroitin sulfate by sulfating free hydroxyl groups in the molecule followed by chemical digestion into smaller, lower molecular weight fragments and purification to form the active ingredient.
Adora is a niche biopharmaceutical company based in Franklin with manufacturing operations in Rensselaer, NY.
From Memphis:
UpSquad, a Memphis-based innovative program community platform provider, is one of nine companies selected for the Startup Junkie Foundation‘s fifth accelerator for artificial intelligence and machine learning start-ups. The 10-week Fuel Accelerator starts August 27. It is a no-cost and no-equity accelerator that’s based in Northwest Arkansas and includes office space at Ledger in Bentonville. The program is designed to help seed and growth-stage technology start-ups become enterprise-ready. The Fuel Accelerator is supported by the Arkansas Economic Development Commission and the Walton Family Foundation.
Given the decline in interest from consumers in electric vehicles, last week’s announcement that Ford Motor Company was delaying the launch of production of its next-generation electric truck at BlueOval City in Stanton was not surprising. BlueOval City was originally scheduled to come online in 2025 with production of the vehicle scheduled for 2026.
Now, according to this announcement from Ford, the company “is retiming the launch of its groundbreaking electric truck code-named ‘Project T3’ to the second half of 2027. Taking all the learnings from F-150 Lightning customers, the truck will offer features and experiences never seen on any Ford truck, including upgraded bi-directional charging capability and advanced aerodynamics. Retiming the launch allows the company to utilize lower-cost battery technology and take advantage of other cost breakthroughs while the market continues to develop.”
Like what you've read?
Forward to a friend!